125 related articles for article (PubMed ID: 32293247)
1. TarPan: an easily adaptable targeted sequencing panel viewer for research and clinical use.
Ashby C; Rutherford M; Bauer MA; Peterson EA; Wang Y; Boyle EM; Wardell CP; Walker BA
BMC Bioinformatics; 2020 Apr; 21(1):144. PubMed ID: 32293247
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
Bai Y; Ding L; Baker S; Bai JM; Rath E; Jiang F; Wu J; Jiang H; Stuart G
BMC Bioinformatics; 2016 Oct; 17(Suppl 13):336. PubMed ID: 27766936
[TBL] [Abstract][Full Text] [Related]
3. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing.
Shen R; Seshan VE
Nucleic Acids Res; 2016 Sep; 44(16):e131. PubMed ID: 27270079
[TBL] [Abstract][Full Text] [Related]
4. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
5. GMIEC: a shiny application for the identification of gene-targeted drugs for precision medicine.
Malagoli Tagliazucchi G; Taccioli C
BMC Genomics; 2020 Sep; 21(1):619. PubMed ID: 32912170
[TBL] [Abstract][Full Text] [Related]
6. D3Oncoprint: Stand-Alone Software to Visualize and Dynamically Explore Annotated Genomic Mutation Files.
Palmisano A; Zhao Y; Simon RM
JCO Clin Cancer Inform; 2018 Dec; 2():1-9. PubMed ID: 30652557
[TBL] [Abstract][Full Text] [Related]
7. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
8. Ioncopy: an R Shiny app to call copy number alterations in targeted NGS data.
Budczies J; Pfarr N; Romanovsky E; Endris V; Stenzinger A; Denkert C
BMC Bioinformatics; 2018 Apr; 19(1):157. PubMed ID: 29699497
[TBL] [Abstract][Full Text] [Related]
9. SRAdb: query and use public next-generation sequencing data from within R.
Zhu Y; Stephens RM; Meltzer PS; Davis SR
BMC Bioinformatics; 2013 Jan; 14():19. PubMed ID: 23323543
[TBL] [Abstract][Full Text] [Related]
10. SomaticSeq: An Ensemble and Machine Learning Method to Detect Somatic Mutations.
Fang LT
Methods Mol Biol; 2020; 2120():47-70. PubMed ID: 32124311
[TBL] [Abstract][Full Text] [Related]
11. Evaluating somatic tumor mutation detection without matched normal samples.
Teer JK; Zhang Y; Chen L; Welsh EA; Cress WD; Eschrich SA; Berglund AE
Hum Genomics; 2017 Sep; 11(1):22. PubMed ID: 28870239
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide Copy Number Variation Detection Using NGS: Data Analysis and Interpretation.
Shen W; Szankasi P; Durtschi J; Kelley TW; Xu X
Methods Mol Biol; 2019; 1908():113-124. PubMed ID: 30649724
[TBL] [Abstract][Full Text] [Related]
13. Clinical target sequencing for precision medicine of breast cancer.
Tsuchida J; Rothman J; McDonald KA; Nagahashi M; Takabe K; Wakai T
Int J Clin Oncol; 2019 Feb; 24(2):131-140. PubMed ID: 30604156
[TBL] [Abstract][Full Text] [Related]
14. Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma.
Sudha P; Ahsan A; Ashby C; Kausar T; Khera A; Kazeroun MH; Hsu CC; Wang L; Fitzsimons E; Salminen O; Blaney P; Czader M; Williams J; Abu Zaid MI; Ansari-Pour N; Yong KL; van Rhee F; Pierceall WE; Morgan GJ; Flynt E; Gooding S; Abonour R; Ramasamy K; Thakurta A; Walker BA
Clin Cancer Res; 2022 Jul; 28(13):2854-2864. PubMed ID: 35522533
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy according to next generation sequencing-based panel sequencing.
Saito M; Momma T; Kono K
Fukushima J Med Sci; 2018 Apr; 64(1):9-14. PubMed ID: 29628467
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management.
Hung SS; Meissner B; Chavez EA; Ben-Neriah S; Ennishi D; Jones MR; Shulha HP; Chan FC; Boyle M; Kridel R; Gascoyne RD; Mungall AJ; Marra MA; Scott DW; Connors JM; Steidl C
J Mol Diagn; 2018 Mar; 20(2):203-214. PubMed ID: 29429887
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of copy number variation detection tools for cancer using whole exome sequencing data.
Zare F; Dow M; Monteleone N; Hosny A; Nabavi S
BMC Bioinformatics; 2017 May; 18(1):286. PubMed ID: 28569140
[TBL] [Abstract][Full Text] [Related]
18. Genomics-Enabled Precision Medicine for Cancer.
Roos A; Byron SA
Cancer Treat Res; 2019; 178():137-169. PubMed ID: 31209844
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data.
Alkodsi A; Louhimo R; Hautaniemi S
Brief Bioinform; 2015 Mar; 16(2):242-54. PubMed ID: 24599115
[TBL] [Abstract][Full Text] [Related]
20. SNPitty: An Intuitive Web Application for Interactive B-Allele Frequency and Copy Number Visualization of Next-Generation Sequencing Data.
van Riet J; Krol NMG; Atmodimedjo PN; Brosens E; van IJcken WFJ; Jansen MPHM; Martens JWM; Looijenga LH; Jenster G; Dubbink HJ; Dinjens WNM; van de Werken HJG
J Mol Diagn; 2018 Mar; 20(2):166-176. PubMed ID: 29305224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]